Technology News and Research

RSS

New Techna Institute at UHN signs first agreement with INO

The new Techna Institute at University Health Network (UHN) has signed its first agreement with INO of Quebec City and Hamilton.

24 Nov 2011

Symphony, Bruker sign supply contract for XRF taggant technology

After a one year cooperative development, Bruker Corporation and Symphony Environmental Ltd have signed a contract for the exclusive supply of Bruker's X-Ray Fluorescence (XRF) taggant technology to Symphony for the identification of pro-degradant, anti-microbial and anti-fungal additives in plastic.

24 Nov 2011

Philips launches Veradius Neo mobile C-arm with flat detector for orthopedic procedures

Royal Philips Electronics today introduced the Philips Veradius Neo mobile C-arm with flat detector to allow surgeons to more easily and precisely handle challenging patients and procedures.

From Philips Healthcare 24 Nov 2011

Anesthesia & Analgesia introduces new electronic edition

The editors of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS), are pleased to announce the launch of their new Anesthesia & Analgesia for the iPad app.

24 Nov 2011

CIC microGUNE and Biodonostia test a new technique for evaluating intestinal diseases in patients

The CIC microGUNE research centre and the Biodonostia Institute have recently started testing a new technique for assessing the severity of inflammatory intestinal diseases, such as Crohn's Disease, in patients at the Donostia Hospital.

23 Nov 2011

Live cell encapsulation technology helps overcome obstacles facing applications of live stem cell usage

Nuvilex, Inc. announced today testing confirmed that through use of live cell encapsulation technology, two major obstacles facing the vast and broad applications of live stem cell use have been overcome.

23 Nov 2011

Imaging is about finding the most appropriate way to assess heart disease

"The idea is that we're using the most appropriate technology to address individual clinical questions rather than just focusing on one technique," explains EAE President Dr Luigi Badano, from the University of Padua, Italy.

23 Nov 2011

BIOTRONIK announces first implantations of new Lumax 740 ICDs

BIOTRONIK, a leading manufacturer of innovative medical technology, announced today the first implantations of the new Lumax 740 implantable cardiac defibrillators—the world's first and only ICDs eligible for use with magnetic resonance imaging.

23 Nov 2011

University of Rochester receives U.S. patent for HPV vaccine research

The University of Rochester has been awarded a U.S. patent for research essential to both human papillomavirus vaccines on the market.

23 Nov 2011

Accelr8 expands development plan for BACcel rapid diagnostic test

Accelr8 Technology Corporation announced that it successfully completed two technical feasibility studies for test methods that expand its BACcel rapid diagnostic test library and automation capabilities.

23 Nov 2011

GPS at WUSTL now offers new cancer genetic test

Physicians can now take advantage of a new genetics test -- one of the first of its kind to be offered in the United States -- that can help determine the best treatment for cancer patients.

23 Nov 2011

Study evaluates safety and effectiveness of Diamondback device for heart attacks

Drilling through concrete to create an opening may sound more like construction than medicine, but the approach is similar to what researchers at Orlando Regional Medical Center (ORMC) are doing in a clinical trial to evaluate a device that breaks through hardened coronary arteries, in an effort to prevent heart attacks and relieve chest pain.

23 Nov 2011

Medicare to cover infusion costs for prostate cancer vaccine, company says

In Medicare news, the drug maker Dendreon says federal officials have said they will pay doctors to administer the drug. Also, policymakers are studying Medigap to see if curbs on those policies could help cut Medicare costs.

23 Nov 2011

Bioengineering delivers innovative solutions to diagnose and repair TBI

Bioengineering -- the application of engineering principles to understand and treat medical conditions -- is delivering innovative solutions for diagnosing and repairing damage to the brain caused by a traumatic injury.

23 Nov 2011

EpiGen to collaborate with Nestl- Research Center in Switzerland

The EpiGen Consortium, an international alliance of the world's leading epigenetics researchers (Singapore Institute for Clinical Sciences of the Agency for Science, Technology and Research (A*STAR), National University of Singapore, University of Southampton, Medical Research Council - Lifecourse Epidemiology Unit, AgResearch Limited, Auckland UniServices Limited) are pleased to announce the creation of a research collaboration with Nestl- Research Center in Switzerland.

23 Nov 2011

Pall applies patent with USPTO for disposable, closed cell collection and seeding system

Pall Corporation, a global leader in filtration, separation and purification, has applied for a patent with the United States Patent and Trademark Office (USPTO) for a disposable, closed cell collection and seeding system that is being developed for use in ground-breaking vein regeneration procedures.

From Pall Corporation 23 Nov 2011

FDA approves Medtronic's iPro2 Professional continuous glucose monitoring system

Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a series of recent diabetes technology approvals and innovations from the company.

From Medtronic 22 Nov 2011

IsoRay receives Washington State approval for GliaSite system to treat brain cancer

IsoRay, Inc. announced today it has received final approval from the State of Washington Department of Health to manufacture its GliaSite radiation therapy system, a balloon catheter device used in the treatment of brain cancer. In conjunction with the previously announced FDA clearance, the Washington State approval represents IsoRay's final regulatory hurdle to commence the sale of its GliaSite brain cancer treatment in the United States.

22 Nov 2011

Naltrexone for problem gamblers

According to new practice guidelines Australian doctors treating gambling addicts now can consider prescribing an anti-heroin drug, naltrexone, to help problem gamblers control their impulses. Australia has one of the world’s highest rates of problem gamblers, with about 2.1 per cent of Australians experiencing some form of gambling problem.

22 Nov 2011

PAREXEL implements fMRI technology in early phase CNS drug development

PAREXEL International, a leading global biopharmaceutical services provider, today announced that it has enhanced its central nervous system (CNS) capabilities for clinical development through the implementation of functional magnetic resonance imaging (fMRI) technology in its Early Phase units.

From Parexel 22 Nov 2011